title: Treatment of infantile primary pulmonary hypertension by intravenous infusion of lipo-prostaglandin I2 analog.
abstract: We used a new vasodilator, TTC-909 (a prostaglandin I2 analog incorporated in lipid microspheres), which produced marked reduction in the pulmonary arterial pressure and resistance in an infant with primary pulmonary hypertension.
authors.affiliation: Department of Pediatrics, Yokohama City University School of Medicine, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takigiku
authors.forename: T
authors.initials: T
authors.lastname: Shibata
authors.forename: K
authors.initials: K
authors.lastname: Yasui
authors.forename: M
authors.initials: M
authors.lastname: Iwamoto
authors.forename: K
authors.initials: K
authors.lastname: Sagawa
authors.forename: K
authors.initials: K
authors.lastname: Yamaoka
authors.forename: N
authors.initials: N
authors.lastname: Tsuda
mesh_terms: D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007223:Infant; D007262:Infusions, Intravenous; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: C068518:TTC 909; D014665:Vasodilator Agents; D011464:Epoprostenol